Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takayuki Fukui

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Asia Pacific Family Medicine|December 17, 2013
Restructuring the Ikeda City school urinary screening system: report of a screening surveyNobuyuki Kajiwara, Kazuyuki Hayashi, Takayuki Fukui, et al.
International Journal of Oncology|August 9, 2016
Increased expression levels of ppGalNAc-T13 in lung cancers: Significance in the prognostic diagnosisKenichi Nogimori, Tomoko Hori, Koji Kawaguchi, et al.
International Journal of Oncology|December 14, 2016
[Corrigendum] Increased expression levels of ppGalNAc-T13 in lung cancers: Significance in the prognostic diagnosisKenichi Nogimori, Tomoko Hori, Koji Kawaguchi, et al.
International Journal of Cancer|November 11, 2006
RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell lineNaohito Sato, Takayuki Fukui, Tetsuo Taniguchi, et al.
Carcinogenesis|April 22, 2009
Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cellsKoji Kawaguchi, Hideki Murakami, Tetsuo Taniguchi, et al.
Life Science Alliance|March 3, 2022
Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockadeYuki Miyai, Daisuke Sugiyama, Tetsunari Hase, et al.
Ebiomedicine|January 26, 2020
Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancerYoshitaka Isobe, Kazuhide Sato, Yuko Nishinaga, et al.
Cancer Science|February 7, 2017
Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancerTomohiko Kakumu, Mitsuo Sato, Daiki Goto, et al.
Oncology Reports|July 25, 2020
Connective tissue growth factor produced by cancer‑associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesotheliomaYuuki Ohara, Atsushi Enomoto, Yuta Tsuyuki, et al.
Cancer Science|May 2, 2021
CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulationHanxiao Shi, Atsuko Niimi, Toshiyuki Takeuchi, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Asia Pacific Family Medicine|December 17, 2013
Restructuring the Ikeda City school urinary screening system: report of a screening surveyNobuyuki Kajiwara, Kazuyuki Hayashi, Takayuki Fukui, et al.
International Journal of Oncology|August 9, 2016
Increased expression levels of ppGalNAc-T13 in lung cancers: Significance in the prognostic diagnosisKenichi Nogimori, Tomoko Hori, Koji Kawaguchi, et al.
International Journal of Oncology|December 14, 2016
[Corrigendum] Increased expression levels of ppGalNAc-T13 in lung cancers: Significance in the prognostic diagnosisKenichi Nogimori, Tomoko Hori, Koji Kawaguchi, et al.
International Journal of Cancer|November 11, 2006
RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell lineNaohito Sato, Takayuki Fukui, Tetsuo Taniguchi, et al.
Carcinogenesis|April 22, 2009
Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cellsKoji Kawaguchi, Hideki Murakami, Tetsuo Taniguchi, et al.
Life Science Alliance|March 3, 2022
Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockadeYuki Miyai, Daisuke Sugiyama, Tetsunari Hase, et al.
Ebiomedicine|January 26, 2020
Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancerYoshitaka Isobe, Kazuhide Sato, Yuko Nishinaga, et al.
Cancer Science|February 7, 2017
Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancerTomohiko Kakumu, Mitsuo Sato, Daiki Goto, et al.
Oncology Reports|July 25, 2020
Connective tissue growth factor produced by cancer‑associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesotheliomaYuuki Ohara, Atsushi Enomoto, Yuta Tsuyuki, et al.
Cancer Science|May 2, 2021
CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulationHanxiao Shi, Atsuko Niimi, Toshiyuki Takeuchi, et al.
Pageof 14